Peanut allergy is diagnosed through a combination of skin prick tests, blood tests, and sometimes a supervised oral food challenge. No single test can confirm a peanut allergy on its own, and false positives are surprisingly common: 50 to 60 percent of positive skin prick tests turn out to be wrong, meaning the person can actually eat peanuts without a reaction. That’s why allergists typically use multiple tests together, along with your history of reactions, to reach an accurate diagnosis.
Skin Prick Testing
A skin prick test is usually the first step. A small drop of peanut protein extract is placed on your forearm or back, and a tiny lancet pricks the skin through the drop. If you’re sensitized to peanut, a raised bump (called a wheal) forms within 15 to 20 minutes. A wheal 3 mm or larger than the saline control is generally considered a positive result, though bigger wheals correspond to higher likelihood of true allergy. In one study of peanut-sensitized children, a wheal of 8 mm or larger had a 95% positive predictive value for a clinical reaction.
The test itself takes about 20 minutes of waiting, plus time for the allergist to review results. It’s mildly uncomfortable but not painful. The main limitation is that a positive result only confirms sensitization, not necessarily allergy. Your immune system may recognize peanut protein without actually causing a dangerous reaction when you eat it. That’s why the high false-positive rate matters so much for decision-making.
Medications That Interfere With Testing
Antihistamines suppress the skin’s response and will make the test unreliable. You need to stop taking common antihistamines like cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra), and diphenhydramine (Benadryl) at least 7 days before testing. That includes over-the-counter cold medicines and sleep aids that contain antihistamines. Nasal antihistamine sprays like azelastine also need a 7-day washout. Acid-reducing medications like famotidine (Pepcid) contain a form of antihistamine and should be stopped 1 day before. If you take a tricyclic antidepressant or beta-blocker, let your allergist know well in advance, as these may also need to be paused with your prescribing doctor’s approval.
Blood Tests for Peanut-Specific IgE
A blood test measures the level of peanut-specific IgE antibodies circulating in your bloodstream. Results come back as a number in kU/L. Higher numbers generally mean a higher probability of true allergy, but the relationship isn’t as clean as you might expect. In one large study, a level of 2.35 kU/L (the median in their population) corresponded to only a 14% chance of clinical allergy. Even at 51 kU/L, the probability was just 50%. Some children with levels above 100 kU/L still weren’t actually allergic.
The cutoff levels that predict allergy with 95% confidence vary wildly between studies, ranging from 15 to 57 kU/L depending on the population studied. This wide range is one reason blood tests alone can’t give you a definitive answer. They’re most useful when combined with skin testing and your reaction history to build an overall picture.
Blood tests have one practical advantage: they don’t require you to stop any medications, and there’s no risk of an allergic reaction during the test itself. They’re often preferred for people with widespread eczema (which makes skin testing difficult) or for those who can’t safely stop antihistamines.
Component Testing for Better Accuracy
Standard blood tests measure your immune response to the whole peanut protein mixture, but newer component testing can identify exactly which peanut proteins your body reacts to. This distinction matters because not all peanut proteins carry the same risk.
The protein called Ara h 2 is the most important marker. It belongs to a group of seed storage proteins, and sensitization to it has the strongest link to serious, systemic allergic reactions. Testing for Ara h 2 provides the best predictive value of any single marker for true peanut allergy.
On the other end of the spectrum, Ara h 8 is a protein that closely resembles birch pollen allergens. Many people who test positive for peanut allergy, especially in regions with lots of birch trees, are actually reacting to this cross-reactive protein rather than to peanut itself. Children and adolescents who only show sensitization to Ara h 8, with no response to seed storage proteins like Ara h 2, generally don’t experience systemic reactions. They might notice mild tingling in the mouth but are unlikely to have anaphylaxis.
If your blood test shows positive Ara h 8 but negative Ara h 2, your allergist may determine that your “peanut allergy” is really a birch pollen cross-reaction with low clinical significance. This kind of precision can prevent unnecessary dietary restrictions.
The Oral Food Challenge
An oral food challenge is the gold standard for diagnosing peanut allergy. It’s the only test that shows what actually happens when you eat peanut. During a challenge, you eat gradually increasing amounts of peanut protein under medical supervision, starting with a tiny dose and working up over several hours. Protocols vary, but one common approach uses incremental doses up to a cumulative total of 4,000 mg of peanut protein (roughly equivalent to about 13 peanuts).
The challenge is stopped immediately if you develop any symptoms: hives, swelling, vomiting, breathing difficulty, or a drop in blood pressure. If you tolerate the full dose without reacting, peanut allergy is effectively ruled out. Because reactions can be severe, these challenges are always done in a clinical setting with emergency equipment on hand.
Oral food challenges are typically reserved for cases where skin and blood tests are ambiguous, or when there’s reason to believe a child may have outgrown their allergy. They’re time-intensive, usually taking 2 to 4 hours, and carry real risk, so allergists don’t order them casually.
When Infants Should Be Tested
Current guidelines from the National Institute of Allergy and Infectious Diseases focus on early introduction of peanut to prevent allergy from developing in the first place. The recommendations depend on the infant’s risk level.
- High-risk infants (severe eczema, egg allergy, or both) should be tested before peanut introduction, ideally between 4 and 6 months of age. Testing with a blood draw or skin prick helps determine whether peanut can be introduced at home or needs to happen under medical supervision. If a skin prick wheal is 2 mm or smaller, home introduction is appropriate. A wheal of 3 to 7 mm calls for a supervised feeding at a specialist’s office. A wheal of 8 mm or larger indicates a high likelihood of existing allergy and requires ongoing specialist management.
- Moderate-risk infants (mild to moderate eczema) can generally start peanut-containing foods around 6 months at home, without formal testing beforehand.
- Low-risk infants (no eczema, no food allergies) can have peanut-containing foods introduced freely alongside other solids, following family preferences.
These guidelines shifted the approach to peanut allergy dramatically. Rather than avoiding peanut in early childhood, the evidence now strongly supports early exposure as protective, particularly for babies already showing signs of allergic disease.
What a Diagnosis Actually Looks Like
Because no single test is reliable enough on its own, allergists piece together multiple sources of information. A typical evaluation starts with your history: what you ate, what symptoms you had, how quickly they appeared, and how severe they were. Skin prick testing and blood work narrow the picture. Component testing can clarify ambiguous results. And when the answer still isn’t clear, an oral food challenge settles it.
If you’ve never had a reaction but tested positive incidentally (during screening for another allergy, for example), there’s a meaningful chance you’re not truly allergic. The high false-positive rate on both skin and blood tests means that a positive result without a history of reactions should prompt further evaluation rather than an immediate peanut-free diet. Unnecessary avoidance of peanut carries its own costs: nutritional limitations, social burden, and anxiety that may not be warranted.